# Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer

> **NCT00002684** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Bladder Cancer
- Urethral Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** ifosfamide
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00002684
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-05
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002684, "Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*